Skip to main content
. 2015 Mar 6;36(4):459–468. doi: 10.1093/carcin/bgv017

Figure 1.

Figure 1.

IL-6 induces EMT changes and Fra-1 expresison in CRC cells. (A) Morphology of HT-29 cells treated with or without 50ng/ml IL-6 for 72h under phase contrast microscopy. Scale bar, 20 μm. (B) Immunofluorescent staining for E-cadherin and vimentin in HT-29 cells treated with IL-6 for 72h (nuclei stained with DAPI). Scale bar, 20 μm. (C) Western blots of E-cadherin and vimentin for HT-29 cells incubated with gradient concentrations of IL-6 for 72h. (D) Western blots of EMT markers with specific antibodies in SW480 cells exposed to IL-6 for 72h. (E) Relative mRNA levels of EMT regulators in HT-29 cells treated with IL-6 for 24h (normalized to GAPDH). *P < 0.05. (F) Western blots of Fra-1 and GAPDH from whole-cell lysates extracted from HT-29 and SW480 cells treated with 50ng/ml IL-6 for the indicated times.